메뉴 건너뛰기




Volumn 14, Issue 13, 2015, Pages 2171-2180

Combinatorial action of MicroRNAs let-7 and miR-34 effectively synergizes with erlotinib to suppress non-small cell lung cancer cell proliferation

Author keywords

Epidermal Growth Factor Receptor (EGFR); Erlotinib; KRAS; Let 7; microRNA; miR 34; miRNA; Non small cell lung cancer (NSCLC); Synergy; TP53

Indexed keywords

CISPLATIN; ERLOTINIB; ETOPOSIDE; MICRORNA; MICRORNA 34A; MICRORNA LET 7; PACLITAXEL; PROTEIN P53; RAS PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MIRN34 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN;

EID: 84938526301     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2014.1003008     Document Type: Article
Times cited : (133)

References (54)
  • 2
    • 52649131951 scopus 로고    scopus 로고
    • Lung cancer
    • PMID: 18815398
    • Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008, 359: 1367-1380; PMID: 18815398; http://dx. doi. org/10. 1056/NEJMra0802714.
    • (2008) N Engl J Med , vol.359 , pp. 1367-1380
    • Herbst, R.S.1    Heymach, J.V.2    Lippman, S.M.3
  • 3
    • 20244381389 scopus 로고    scopus 로고
    • Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent nonsmall-cell lung cancer
    • PMID: 15753462
    • Herbst RS, Johnson DH, Mininberg E, Carbone DP, Henderson T, Kim ES, Blumenschein G, Jr., Lee JJ, Liu DD, Truong MT, et al. Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent nonsmall-cell lung cancer. J Clin Oncol 2005, 23: 2544-2555; PMID: 15753462; http://dx. doi. org/10. 1200/JCO. 2005. 02. 477.
    • (2005) J Clin Oncol , vol.23 , pp. 2544-2555
    • Herbst, R.S.1    Johnson, D.H.2    Mininberg, E.3    Carbone, D.P.4    Henderson, T.5    Kim, E.S.6    Blumenschein, G.7    Lee, J.J.8    Liu, D.D.9    Truong, M.T.10
  • 4
    • 0037639968 scopus 로고    scopus 로고
    • Molecular genetics of lung cancer
    • PMID: 12471176
    • Sekido Y, Fong KM, Minna JD. Molecular genetics of lung cancer. Ann Rev Med 2003, 54: 73-87; PMID: 12471176; http://dx. doi. org/10. 1146/annurev. med. 54. 101601. 152202.
    • (2003) Ann Rev Med , vol.54 , pp. 73-87
    • Sekido, Y.1    Fong, K.M.2    Minna, J.D.3
  • 5
    • 0036463481 scopus 로고    scopus 로고
    • Focus on lung cancer
    • PMID: 12086887
    • Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell 2002, 1: 49-52; PMID: 12086887; http://dx. doi. org/10. 1016/S1535-6108(02)00027-2.
    • (2002) Cancer Cell , vol.1 , pp. 49-52
    • Minna, J.D.1    Roth, J.A.2    Gazdar, A.F.3
  • 6
    • 62549110421 scopus 로고    scopus 로고
    • Beyond doublet chemotherapy for advanced non-small-cell lung cancer: Combination of targeted agents with first-line chemotherapy
    • PMID: 19289368
    • Herbst RS, Lynch TJ, Sandler AB. Beyond doublet chemotherapy for advanced non-small-cell lung cancer: combination of targeted agents with first-line chemotherapy. Clin Lung Cancer 2009, 10: 20-27; PMID: 19289368; http://dx. doi. org/10. 3816/CLC. 2009. n. 003.
    • (2009) Clin Lung Cancer , vol.10 , pp. 20-27
    • Herbst, R.S.1    Lynch, T.J.2    Sandler, A.B.3
  • 7
    • 41149097557 scopus 로고    scopus 로고
    • Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib
    • PMID: 18349398
    • Miller VA, Riely GJ, Zakowski MF, Li AR, Patel JD, Heelan RT, Kris MG, Sandler AB, Carbone DP, Tsao A, et al. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib. J Clin Oncol 2008, 26: 1472-1478; PMID: 18349398; http://dx. doi. org/10. 1200/JCO. 2007. 13. 0062.
    • (2008) J Clin Oncol , vol.26 , pp. 1472-1478
    • Miller, V.A.1    Riely, G.J.2    Zakowski, M.F.3    Li, A.R.4    Patel, J.D.5    Heelan, R.T.6    Kris, M.G.7    Sandler, A.B.8    Carbone, D.P.9    Tsao, A.10
  • 8
    • 0033063774 scopus 로고    scopus 로고
    • The epidermal growth factor receptor and its inhibition in cancer therapy
    • PMID: 10454201
    • Woodburn JR. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 1999, 82: 241-250; PMID: 10454201; http://dx. doi. org/10. 1016/S0163-7258(98)00045-X.
    • (1999) Pharmacol Ther , vol.82 , pp. 241-250
    • Woodburn, J.R.1
  • 9
    • 0034778447 scopus 로고    scopus 로고
    • EGFR and cancer prognosis
    • Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer 2001, 37 Suppl 4: S9-15; http://dx. doi. org/10. 1016/S0959-8049(01)00231-3.
    • (2001) Eur J Cancer , vol.37 , pp. 9-15
    • Nicholson, R.I.1    Gee, J.M.2    Harper, M.E.3
  • 10
    • 0037890342 scopus 로고    scopus 로고
    • Early glandular neoplasia of the lung
    • PMID: 11667981
    • Westra WH. Early glandular neoplasia of the lung. Respir Res 2000, 1: 163-169; PMID: 11667981; http://dx. doi. org/10. 1186/rr28.
    • (2000) Respir Res , vol.1 , pp. 163-169
    • Westra, W.H.1
  • 11
    • 24744461722 scopus 로고    scopus 로고
    • EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients
    • PMID: 16140919
    • Tang X, Shigematsu H, Bekele BN, Roth JA, Minna JD, Hong WK, Gazdar AF, Wistuba II. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res 2005, 65: 7568-7572; PMID: 16140919.
    • (2005) Cancer Res , vol.65 , pp. 7568-7572
    • Tang, X.1    Shigematsu, H.2    Bekele, B.N.3    Roth, J.A.4    Minna, J.D.5    Hong, W.K.6    Gazdar, A.F.7    Wistuba, I.I.8
  • 12
    • 56749173617 scopus 로고    scopus 로고
    • Bevacizumab and erlotinib: A promising new approach to the treatment of advanced NSCLC
    • PMID: 18997180
    • Herbst RS, Sandler A. Bevacizumab and erlotinib: a promising new approach to the treatment of advanced NSCLC. Oncologist 2008, 13: 1166-1176; PMID: 18997180; http://dx. doi. org/10. 1634/theoncologist. 2008-0108.
    • (2008) Oncologist , vol.13 , pp. 1166-1176
    • Herbst, R.S.1    Sandler, A.2
  • 13
    • 33847323129 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutations in lung cancer
    • PMID: 17318210
    • Sharma SV, Bell DW, Settleman J, Haber DA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007, 7: 169-181; PMID: 17318210; http://dx. doi. org/10. 1038/nrc2088.
    • (2007) Nat Rev Cancer , vol.7 , pp. 169-181
    • Sharma, S.V.1    Bell, D.W.2    Settleman, J.3    Haber, D.A.4
  • 14
    • 33947498978 scopus 로고    scopus 로고
    • Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer
    • PMID: 17290067
    • Sequist LV, Bell DW, Lynch TJ, Haber DA. Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. J Clin Oncol 2007, 25: 587-595; PMID: 17290067; http://dx. doi. org/10. 1200/JCO. 2006. 07. 3585.
    • (2007) J Clin Oncol , vol.25 , pp. 587-595
    • Sequist, L.V.1    Bell, D.W.2    Lynch, T.J.3    Haber, D.A.4
  • 15
    • 18244371651 scopus 로고    scopus 로고
    • Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
    • PMID: 15737014
    • Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, Kris MG, Varmus H. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2005, 2: e73; PMID: 15737014; http://dx. doi. org/10. 1371/journal. pmed. 0020073.
    • (2005) PLoS Med , vol.2
    • Pao, W.1    Miller, V.A.2    Politi, K.A.3    Riely, G.J.4    Somwar, R.5    Zakowski, M.F.6    Kris, M.G.7    Varmus, H.8
  • 17
    • 24944497744 scopus 로고    scopus 로고
    • Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
    • PMID: 16043828
    • Eberhard DA, Johnson BE, Amler LC, Goddard AD, Heldens SL, Herbst RS, Ince WL, Janne PA, Januario T, Johnson DH, et al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 2005, 23: 5900-5909; PMID: 16043828; http://dx. doi. org/10. 1200/JCO. 2005. 02. 857.
    • (2005) J Clin Oncol , vol.23 , pp. 5900-5909
    • Eberhard, D.A.1    Johnson, B.E.2    Amler, L.C.3    Goddard, A.D.4    Heldens, S.L.5    Herbst, R.S.6    Ince, W.L.7    Janne, P.A.8    Januario, T.9    Johnson, D.H.10
  • 18
    • 53249145767 scopus 로고    scopus 로고
    • Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma
    • PMID: 18794081
    • Riely GJ, Kris MG, Rosenbaum D, Marks J, Li A, Chitale DA, Nafa K, Riedel ER, Hsu M, Pao W, et al. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clin Cancer Res 2008, 14: 5731-5734; PMID: 18794081; http://dx. doi. org/10. 1158/1078-0432. CCR-08-0646.
    • (2008) Clin Cancer Res , vol.14 , pp. 5731-5734
    • Riely, G.J.1    Kris, M.G.2    Rosenbaum, D.3    Marks, J.4    Li, A.5    Chitale, D.A.6    Nafa, K.7    Riedel, E.R.8    Hsu, M.9    Pao, W.10
  • 19
    • 38049150665 scopus 로고    scopus 로고
    • MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
    • PMID: 18093943
    • Bean J, Brennan C, Shih JY, Riely G, Viale A, Wang L, Chitale D, Motoi N, Szoke J, Broderick S, et al. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci U S A 2007, 104: 20932-20937; PMID: 18093943; http://dx. doi. org/10. 1073/pnas. 0710370104.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 20932-20937
    • Bean, J.1    Brennan, C.2    Shih, J.Y.3    Riely, G.4    Viale, A.5    Wang, L.6    Chitale, D.7    Motoi, N.8    Szoke, J.9    Broderick, S.10
  • 22
    • 33748074447 scopus 로고    scopus 로고
    • Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer
    • PMID: 16912157
    • Inukai M, Toyooka S, Ito S, Asano H, Ichihara S, Soh J, Suehisa H, Ouchida M, Aoe K, Aoe M, et al. Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer. Cancer Res 2006, 66: 7854-7858; PMID: 16912157; http://dx. doi. org/10. 1158/0008-5472. CAN-06-1951.
    • (2006) Cancer Res , vol.66 , pp. 7854-7858
    • Inukai, M.1    Toyooka, S.2    Ito, S.3    Asano, H.4    Ichihara, S.5    Soh, J.6    Suehisa, H.7    Ouchida, M.8    Aoe, K.9    Aoe, M.10
  • 23
    • 34648815009 scopus 로고    scopus 로고
    • Lung cancer in never smokers-a different disease
    • PMID: 17882278
    • Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007, 7: 778-790; PMID: 17882278; http://dx. doi. org/10. 1038/nrc2190.
    • (2007) Nat Rev Cancer , vol.7 , pp. 778-790
    • Sun, S.1    Schiller, J.H.2    Gazdar, A.F.3
  • 24
    • 0037152658 scopus 로고    scopus 로고
    • Smoking molecular damage in bronchial epithelium
    • PMID: 12379874
    • Wistuba II, Mao L, Gazdar AF. Smoking molecular damage in bronchial epithelium. Oncogene 2002, 21: 7298-7306; PMID: 12379874; http://dx. doi. org/10. 1038/sj. onc. 1205806.
    • (2002) Oncogene , vol.21 , pp. 7298-7306
    • Wistuba, I.I.1    Mao, L.2    Gazdar, A.F.3
  • 28
    • 34250868124 scopus 로고    scopus 로고
    • Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: MiR-34a is a p53 target that induces apoptosis and G1-arrest
    • PMID: 17554199
    • Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G, Hermeking H. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007, 6: 1586-1593; PMID: 17554199; http://dx. doi. org/10. 4161/cc. 6. 13. 4436.
    • (2007) Cell Cycle , vol.6 , pp. 1586-1593
    • Tarasov, V.1    Jung, P.2    Verdoodt, B.3    Lodygin, D.4    Epanchintsev, A.5    Menssen, A.6    Meister, G.7    Hermeking, H.8
  • 29
    • 34249822779 scopus 로고    scopus 로고
    • Transcriptional activation of miR-34a contributes to p53-mediated apoptosis
    • PMID: 17540598
    • Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007, 26: 731-743; PMID: 17540598; http://dx. doi. org/10. 1016/j. molcel. 2007. 05. 017.
    • (2007) Mol Cell , vol.26 , pp. 731-743
    • Raver-Shapira, N.1    Marciano, E.2    Meiri, E.3    Spector, Y.4    Rosenfeld, N.5    Moskovits, N.6    Bentwich, Z.7    Oren, M.8
  • 31
    • 79960211493 scopus 로고    scopus 로고
    • Tumour-suppressor micro-RNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
    • PMID: 21654684
    • Buechner J, Tomte E, Haug BH, Henriksen JR, Lokke C, Flaegstad T, Einvik C. Tumour-suppressor micro-RNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Br J Cancer 2011, 105: 296-303; PMID: 21654684; http://dx. doi. org/10. 1038/bjc. 2011. 220.
    • (2011) Br J Cancer , vol.105 , pp. 296-303
    • Buechner, J.1    Tomte, E.2    Haug, B.H.3    Henriksen, J.R.4    Lokke, C.5    Flaegstad, T.6    Einvik, C.7
  • 32
    • 68149165414 scopus 로고    scopus 로고
    • HuR recruits let-7/RISC to repress c-Myc expression
    • PMID: 19574298
    • Kim HH, Kuwano Y, Srikantan S, Lee EK, Martindale JL, Gorospe M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev 2009, 23: 1743-1748; PMID: 19574298; http://dx. doi. org/10. 1101/gad. 1812509.
    • (2009) Genes Dev , vol.23 , pp. 1743-1748
    • Kim, H.H.1    Kuwano, Y.2    Srikantan, S.3    Lee, E.K.4    Martindale, J.L.5    Gorospe, M.6
  • 33
    • 2542626605 scopus 로고    scopus 로고
    • Reduced expression of the let-7 micro-RNAs in human lung cancers in association with shortened postoperative survival
    • PMID: 15172979
    • Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, et al. Reduced expression of the let-7 micro-RNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64: 3753-3756; PMID: 15172979; http://dx. doi. org/10. 1158/0008-5472. CAN-04-0637.
    • (2004) Cancer Res , vol.64 , pp. 3753-3756
    • Takamizawa, J.1    Konishi, H.2    Yanagisawa, K.3    Tomida, S.4    Osada, H.5    Endoh, H.6    Harano, T.7    Yatabe, Y.8    Nagino, M.9    Nimura, Y.10
  • 34
    • 34247565615 scopus 로고    scopus 로고
    • The tumor suppressor microRNA let-7 represses the HMGA2 oncogene
    • PMID: 17437991
    • Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007, 21: 1025-1030; PMID: 17437991; http://dx. doi. org/10. 1101/gad. 1540407.
    • (2007) Genes Dev , vol.21 , pp. 1025-1030
    • Lee, Y.S.1    Dutta, A.2
  • 35
    • 40849108663 scopus 로고    scopus 로고
    • Selective blockade of microRNA processing by Lin28
    • PMID: 18292307
    • Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science 2008, 320: 97-100; PMID: 18292307; http://dx. doi. org/10. 1126/science. 1154040.
    • (2008) Science , vol.320 , pp. 97-100
    • Viswanathan, S.R.1    Daley, G.Q.2    Gregory, R.I.3
  • 36
    • 80051613002 scopus 로고    scopus 로고
    • Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis
    • Kaller M, Liffers ST, Oeljeklaus S, Kuhlmann K, Roh S, Hoffmann R, Warscheid B, Hermeking H. Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis. Mol Cell Proteomics 2011, 10: M111 010462; http://dx. doi. org/10. 1074/mcp. M111. 010462.
    • (2011) Mol Cell Proteomics , vol.10
    • Kaller, M.1    Liffers, S.T.2    Oeljeklaus, S.3    Kuhlmann, K.4    Roh, S.5    Hoffmann, R.6    Warscheid, B.7    Hermeking, H.8
  • 38
    • 84906258538 scopus 로고    scopus 로고
    • Aberrant regulation and function of microRNAs in cancer
    • PMID: 25137592
    • Adams BD, Kasinski AL, Slack FJ. Aberrant regulation and function of microRNAs in cancer. Curr Biol 2014, 24: R762-776; PMID: 25137592; http://dx. doi. org/10. 1016/j. cub. 2014. 06. 043.
    • (2014) Curr Biol , vol.24 , pp. 762-776
    • Adams, B.D.1    Kasinski, A.L.2    Slack, F.J.3
  • 39
    • 84868254278 scopus 로고    scopus 로고
    • miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma
    • PMID: 22964582
    • Kasinski AL, Slack FJ. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res 2012, 72: 5576-5587; PMID: 22964582; http://dx. doi. org/10. 1158/0008-5472. CAN-12-2001.
    • (2012) Cancer Res , vol.72 , pp. 5576-5587
    • Kasinski, A.L.1    Slack, F.J.2
  • 40
    • 81855224576 scopus 로고    scopus 로고
    • Epigenetics and genetics. Micro-RNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy
    • PMID: 22113163
    • Kasinski AL, Slack FJ. Epigenetics and genetics. Micro-RNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011, 11: 849-864; PMID: 22113163; http://dx. doi. org/10. 1038/nrc3166.
    • (2011) Nat Rev Cancer , vol.11 , pp. 849-864
    • Kasinski, A.L.1    Slack, F.J.2
  • 41
    • 84902464275 scopus 로고    scopus 로고
    • MicroRNAs and the cancer phenotype: Profiling, signatures and clinical implications
    • PMID: 24373327
    • Stahlhut C, Slack FJ. MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications. Genome Med 2013, 5: 111; PMID: 24373327; http://dx. doi. org/10. 1186/gm516.
    • (2013) Genome Med , vol.5 , pp. 111
    • Stahlhut, C.1    Slack, F.J.2
  • 42
    • 38549182603 scopus 로고    scopus 로고
    • The role of micro-RNAs in cancer
    • PMID: 17940623
    • Stahlhut Espinosa CE, Slack FJ. The role of micro-RNAs in cancer. Yale J Biol Med 2006, 79: 131-140; PMID: 17940623.
    • (2006) Yale J Biol Med , vol.79 , pp. 131-140
    • Stahlhut Espinosa, C.E.1    Slack, F.J.2
  • 44
    • 79957900919 scopus 로고    scopus 로고
    • Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice
    • PMID: 21427705
    • Trang P, Wiggins JF, Daige CL, Cho C, Omotola M, Brown D, Weidhaas JB, Bader AG, Slack FJ. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther 2011, 19: 1116-1122; PMID: 21427705; http://dx. doi. org/10. 1038/mt. 2011. 48.
    • (2011) Mol Ther , vol.19 , pp. 1116-1122
    • Trang, P.1    Wiggins, J.F.2    Daige, C.L.3    Cho, C.4    Omotola, M.5    Brown, D.6    Weidhaas, J.B.7    Bader, A.G.8    Slack, F.J.9
  • 45
    • 77955022405 scopus 로고    scopus 로고
    • Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34
    • PMID: 20570894
    • Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, Bader AG. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 2010, 70: 5923-5930; PMID: 20570894; http://dx. doi. org/10. 1158/0008-5472. CAN-10-0655.
    • (2010) Cancer Res , vol.70 , pp. 5923-5930
    • Wiggins, J.F.1    Ruffino, L.2    Kelnar, K.3    Omotola, M.4    Patrawala, L.5    Brown, D.6    Bader, A.G.7
  • 47
    • 84869219338 scopus 로고    scopus 로고
    • miR-34-a microRNA replacement therapy is headed to the clinic
    • PMID: 22783274
    • Bader AG. miR-34-a microRNA replacement therapy is headed to the clinic. Front Genet 2012, 3: 120; PMID: 22783274; http://dx. doi. org/10. 3389/fgene. 2012. 00120.
    • (2012) Front Genet , vol.3 , pp. 120
    • Bader, A.G.1
  • 49
    • 84895866286 scopus 로고    scopus 로고
    • In-depth analysis shows synergy between erlotinib and miR-34a
    • PMID: 24551227
    • Zhao J, Kelnar K, Bader AG. In-depth analysis shows synergy between erlotinib and miR-34a. PloS One 2014, 9: e89105; PMID: 24551227; http://dx. doi. org/10. 1371/journal. pone. 0089105.
    • (2014) PloS One , vol.9
    • Zhao, J.1    Kelnar, K.2    Bader, A.G.3
  • 50
    • 84904765311 scopus 로고    scopus 로고
    • MicroRNA-34a overcomes HGFmediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET
    • PMID: 24983493
    • Zhou JY, Chen X, Zhao J, Bao Z, Chen X, Zhang P, Liu ZF, Zhou JY. MicroRNA-34a overcomes HGFmediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET. Cancer Lett 2014, 351: 265-271; PMID: 24983493; http://dx. doi. org/10. 1016/j. canlet. 2014. 06. 010.
    • (2014) Cancer Lett , vol.351 , pp. 265-271
    • Zhou, J.Y.1    Chen, X.2    Zhao, J.3    Bao, Z.4    Chen, X.5    Zhang, P.6    Liu, Z.F.7    Zhou, J.Y.8
  • 52
    • 33748794547 scopus 로고    scopus 로고
    • Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
    • PMID: 16968952
    • Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006, 58: 621-681; PMID: 16968952.
    • (2006) Pharmacol Rev , vol.58 , pp. 621-681
    • Chou, T.C.1
  • 54
    • 84893628843 scopus 로고    scopus 로고
    • Quantification of therapeutic miRNA mimics in whole blood from nonhuman primates
    • PMID: 24397447
    • Kelnar K, Peltier HJ, Leatherbury N, Stoudemire J, Bader AG. Quantification of therapeutic miRNA mimics in whole blood from nonhuman primates. Anal Chem 2014, 86: 1534-1542; PMID: 24397447.
    • (2014) Anal Chem , vol.86 , pp. 1534-1542
    • Kelnar, K.1    Peltier, H.J.2    Leatherbury, N.3    Stoudemire, J.4    Bader, A.G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.